ADC Synthesis in Flow

A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization.

Meet four of the scientists testing the ChAdOx1 nCoV-19 vaccine, and find out what the first results say about safety and the immune response it creates in humans.

The first healthy volunteers have now received a candidate coronavirus vaccine developed by Imperial researchers.